Subscribe
shutterstock_325058183_crystal51
crystal51 / Shutterstock.com
9 September 2021AsiaKeith Haddaway and Christopher Loh

Amendments to Chinese Patents Law for the Life Sciences

On June 1, 2021, the fourth amendment of the Chinese patent law went into effect. The amendment contains generally applicable provisions and makes specific changes to design patent law and Life Science-related patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.

More on this story

Americas
Chinese state-owned chemical firm in fungicide patent suit
14 November 2019   A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.
Americas
FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent
13 November 2020   The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.
Asia
China accepts cluster of complaints under new patent linkage law
9 November 2021   The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
ITC concludes row over biotech lab equipment between US and German rivals
Polsinelli expands Hatch-Waxman and litigation practices
Novo Nordisk’s uphill battle in the counterfeit weight loss craze
FTC supports USPTO terminal disclaimer plan amid opposition